Classified in: Health
Subject: PDT
Efpy, the functional beauty brand pioneering “micro-dose wellness” through everyday beauty rituals, is now live on IPSY Wellness. The launch reflects growing consumer demand for wellness experiences integrated into familiar daily routines.
FOSTER CITY, Calif., May 15, 2026 /PRNewswire-PRWeb/ — Efpy Brings Micro-Dose Wellness Rituals to IPSY Wellness
Consumers don’t necessarily want more wellness routines. They want support that fits naturally into real life.
The functional beauty brand expands its presence as beauty and wellness increasingly converge around everyday rituals and emotional wellbeing.
Efpy, the functional beauty brand pioneering “micro-dose wellness” through daily beauty rituals, is now live on IPSY Wellness.
Founded by former Unilever and Google executive Smriti (Sim) Khullar, Efpy was built around a simple behavioral insight: wellness products often fail not because ingredients don’t work, but because habits don’t stick.
Rather than asking consumers to adopt complex new routines, Efpy integrates wellness support into a ritual people already naturally repeat throughout the day ? applying lip balm.
Each Efpy balm combines nourishing lip care with micro-dosed functional ingredients such as L-theanine, B vitamins, green coffee, and botanical extracts, alongside sensory essential oil blends designed to support moments of calm, focus, and everyday wellbeing.
The launch on IPSY Wellness reflects growing consumer demand for products that support emotional wellbeing through seamless, everyday experiences rather than complicated multi-step routines.
“Consumers don’t necessarily want more wellness routines,” said Smriti Khullar, founder of Efpy. “They want support that fits naturally into real life. We created Efpy around the idea that small repeated rituals can become powerful moments of reset throughout the day.”
Efpy’s approach combines functional beauty, behavior-driven product design, and sensory rituals into what the brand calls “micro-dose wellness” ? an emerging category centered around wellness support embedded into everyday rituals.
The IPSY Wellness launch marks another milestone in Efpy’s early growth as the brand continues expanding awareness around functional beauty and ritual-based wellness.
About Efpy
Efpy is a functional beauty brand transforming everyday beauty rituals into moments of wellness support through micro-dosed functional ingredients and sensory rituals. Founded in California, Efpy’s lip balm system combines nourishing lip care with ingredients designed to support calm, focus, energy, and everyday wellbeing ? all through rituals people already naturally repeat throughout the day.
Media Contact:
[email protected]
https://www.efpybeauty.com
Media Contact
Sim Khullar, Efpy Beauty, 1 6509126715, [email protected], www.efpybeauty.com
SOURCE Efpy Beauty
These press releases may also interest you
at 17:00
TuHURA Biosciences, Inc. (“TuHURA” or the “Company”), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today reported financial results for the Company’s first quarter ended March 31,…
at 16:30
Citius Oncology, Inc. (“Citius Oncology” or the “Company”) , the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (“Citius Pharma”) , today reported financial results for the fiscal second quarter ended March 31, 2026, and provided a…
at 16:30
Citius Pharmaceuticals, Inc. (“Citius Pharma” or the “Company”) , a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today reported business and financial results for the fiscal…
at 16:20
Scholar Rock today announced that the company granted inducement equity awards covering an aggregate of 38,481 shares of its common stock to six newly hired employees, consisting of inducement stock options to purchase an aggregate of 12,061 shares…
at 16:15
Agenus Inc. , a leader in immuno-oncology innovation, today announced the publication of Phase 1b data evaluating botensilimab (BOT), an Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, in patients with…
at 16:10
Novanta Inc. (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2026 Global Consumer, Technology &…
News published on 15 may 2026 at 15:10 and distributed by:
